We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients.

Therapeutics

Life Sciences

Health Care

Medical Devices

Multiple Myeloma Research Foundation - MMRF

Michael Andreini

Yolanda Thomas

Mary Grennan M.b.a., Ed.

Lauren Bruce (LB)

Kalsuum Nasser Deen M.D.

Jessica Schulman

Msn Rocio B. Scavino Rn

Katie Bova

Liz Voss

Stephanie Oestreich

Christopher Williams

Olamide Banjo Pharmd, Aahivp

Mary Derome

Karen Dietz Jd

Spencer B.

Greg Rubenstein

Administration and Support

Fundraising and Donor Relations

Leadership Team

Marketing and Communications

Clinical Operations and Patient Services

Alliance Management and Partnerships

Research and Data Analysis

Teams at Multiple Myeloma Research Foundation - MMRF